Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Siegler-Brewer-Carey syndrome is characterized by cataracts, otitis media, intestinal malabsorption, chronic respiratory infection, and failure to thrive. It has been recently described in two sibs born to consanguineous parents. The patients also developed recurrent pneumonia and progressive azotemia leading to end-stage renal disease. Both children died of overwhelming infection (sepsis, meningitis). An autosomal recessive mode of inheritance was proposed.
Biomarker and diagnostic research for Siegler-Brewer-Carey syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Siegler-Brewer-Carey syndrome.
248 publications have been identified in PubMed for Siegler-Brewer-Carey syndrome. Research spans Review / Meta-Analysis (49%), Basic Science / Preclinical (16%), and Case Report / Case Series (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 121 | 49% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Siegler-Brewer-Carey syndrome
40 |
16% |
Patient case studies | 34 | 14% |
Disease patterns and progression | 28 | 11% |
Testing and diagnosis research | 9 | 4% |
Clinical study results | 8 | 3% |
Other research | 6 | 2% |
New treatment approaches | 2 | 1% |
Toljan K (2026). [PMID: 42066585](https://pubmed.ncbi.nlm.nih.gov/42066585/). *J Neurol Sci*. [Basic Science / Preclinical]
Vialle R (2026). [PMID: 40976314](https://pubmed.ncbi.nlm.nih.gov/40976314/). *Orthop Traumatol Surg Res*. [Review / Meta-Analysis]
Anandan S (2026). [PMID: 41818118](https://pubmed.ncbi.nlm.nih.gov/41818118/). *J Assoc Physicians India*. [Case Report / Case Series]
Cioni P (2026). [PMID: 41437650](https://pubmed.ncbi.nlm.nih.gov/41437650/). *Rheumatology (Oxford)*. [Basic Science / Preclinical]
Avelino-Silva TJ (2026). [PMID: 41591773](https://pubmed.ncbi.nlm.nih.gov/41591773/). *JAMA Netw Open*. [Epidemiology / Natural History]
Graafen L (2026). [PMID: 41831046](https://pubmed.ncbi.nlm.nih.gov/41831046/). *J Clin Immunol*. [Diagnostic / Biomarker]
Aguilar AA (2026). [PMID: 41758717](https://pubmed.ncbi.nlm.nih.gov/41758717/). *AACN Adv Crit Care*. [Review / Meta-Analysis]
Wu D (2026). [PMID: 41072814](https://pubmed.ncbi.nlm.nih.gov/41072814/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Asghar E (2026). [PMID: 41401403](https://pubmed.ncbi.nlm.nih.gov/41401403/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Morin G (2026). [PMID: 41173190](https://pubmed.ncbi.nlm.nih.gov/41173190/). *Kidney Int*. [Review / Meta-Analysis]